Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherap...
Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer-Verlag
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer-Verlag
Subjects
More information
Scope and Contents
Contents
Purpose
To evaluate the prognostic significance of excision repair cross-complementation group 1 (ERCC1) expression in head and neck carcinoma patients treated with definitive radiotherapy (DR) or adjuvant radiotherapy (AR).
Methods
ERCC1 expression was assessed by immunohistochemical staining. A total of 48 patients were assessed.
Resu...
Alternative Titles
Full title
Prognostic value of ERCC1 in head and neck carcinoma treated with definitive or adjuvant radiotherapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1273693066
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1273693066
Other Identifiers
ISSN
0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-012-1318-8
